The difference between CDE-treated Fn14 WT and Fn14 KO mice was particularly pronounced at the 3-month time point, where the CK19+ ductal cell population was represented at significantly lower levels in the Fn14 KO animals compared with the wildtype pancreatitis controls. This evidence concerns the gene TNFRSF12A and pancreatitis.